Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: Role of protein phosphatases

Endocrinology

Volumn 139, Issue 5, 1998, Pages 2423-2431

  Hulley, P A ^a   Gordon, F ^a   Hough, F S ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME INHIBITION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0031765105     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.5.6020     Document Type: Article

References (52)

1. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. J Clin Invest 64:655-665
2. Canalis E 1996 Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
3. Bran DW, Hendry LB, Mahesh VB 1995 Emerging diversities in the mechanism of action of steroid hormones. J Steroid Biochem Mol Biol 52:113-133
4. Lukert BP, Raisz LG 1990 Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364
5. Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, Lian JB 1992 Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 50:425-440
6. Seger R, and Krebs EG 1995 The MAPK signaling cascade. FASEB J 9:726-735
7. Marshall CJ 1995 Specificity of receptor tyrosine kinase signaling: Transient us. sustained extracellular signal-regulated kinase activation. Cell 80:179-185
8. Burgering BMT, Bos JL 1995 Regulation of Ras-mediated signalling: more than one way to skin a cat. Trends Biochem Sci 20:18-22
9. Anderson NG, Maller JL, Tonks NK, Sturgill TW 1990 Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 143:651-653
10. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P 1992 Sustained activation of the mitogen activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288:351-355
11. Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT 1993 Novel mechanism for inhibition of human T cells by glucocorticoids: glucocorticoids inhibit signal transduction through IL-2 receptor. J Immunol 151:4081-4089
12. 2+ ionophores, antigen and diacyl glycerol: essential role for protein kinase C and prevention by glucocorticosteroids. Biochem Biophys Acta 1091:385-392
13. Koch HM, Gordon F, Hough FS, Crosstalk between three major signal transduction systems in the regulation of osteoblast proliferation by parathyroid hormone (PTH). American Society for Bone and Mineral Research 15th Annual Meeting, Tampa, FL, 1993, J Bone Miner Res 8, S1:S193 (Abstract)
14. Verheijen MHG, Defize LHK 1995 Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway. Endocrinology 136:3331-3337
15. Siddhanti SR, Hartle JE, Quarles LD 1995 Forskolin inhibits protein kinase C-induced mitogen-activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 136:4834-4841
16. Rider LG, Hirasawa N, Santini F, Beaven MA 1996 Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 157:2374-2380
17. Cambillau C, Rauly I, Sarfati P, Saint-Laurent N, Esteve J-P, Fanjul M, Svoboda M, Prats H, Hollande E, Vaysse N, Susini C 1995 Regulation of the src homology 2 domain-containing protein tyrosine phosphatase PTP1C by glucocorticoids in rat pancreatic AR42J cells. Endocrinology 136:5476-5484
18. Fried A, Benayahu D, Wientroub S 1993 Marrow stroma-derived osteogenic clonal cell lines: Putative stages in osteoblastic differentiation. J Cell Physiol 155:472-482
19. Benayahu D, Kletter Y, Zipori D, Wientroub S 1989 Bone marrow-derived stromal cell line expressing osteoblastic phenotype in vitro and osteogenic capacity in vivo. J Cell Physiol 140:1-7
20. Vallee RB 1982 A Taxol-dependent procedure for the isolation of microtubules and microtubule-associated proteins (MAPs). J Cell Biol 92:435
21. Yamaguchi A, Kahn AJ 1991 Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49:221-225
22. Reid IR, Civitelli R, Avioli LV, Hruska KA 1988 Parathyroid hormone depresses cytosolic pH and DNA synthesis in osteoblast-like cells. Am J Physiol 255:E9-E15
23. Hanekom C, Nel A, Gittinger C, Rheeder A, Landreth G 1989 Complexing of the CD-3 subunit by a monoclonal antibody activates a microtubule-associated protein 2 (MAP-2) serine kinase in Jurkat cells. Biochem J 262:449-456
24. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H 1990 Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesised selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272
25. Bradford MM 1976 A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein:dye binding. Anal Biochem 72:248
26. Lamy F, Wilkin F, Baptist M, Posada J, Roger PP, Dumont JE 1993 Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway. J Biol Chem 268:8398-8401
27. Neel BG, Tonks NK 1997 Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 9:193-204
28. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM, Cohen P 1995 Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol 5:283-295
29. Wu J, Lau LF, Sturgill TW 1994 Rapid deactivation of MAP kinase in PC12 cells occurs independently of induction of phosphatase MKP-1. FEBS Lett 353:9-12
30. Chajry N, Martin P-M, Cochet C, Berthois Y 1996 Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells. Eur J Biochem 235:97-102
31. Haystead TA, Dent P, Wu J, Haystead CM, Sturgill TW 1992 Ordered phosphorylation of p42 MAPK by MAP kinase kinase. FEBS Lett 13:17-22
32. Wu YY, Bradshaw RA 1993 Effect of nerve growth factor and fibroblast growth factor on PC12 cells: Inhibition by orthovanadate. J Cell Biol 121:409-422
33. Dubyak GR, Kleinzeller A 1980 The insulin-mimetic effects of vanadate in isolated rat adipocytes. J Biol Chem 255:5306-5312
34. Den Hertog J, Pals CEGM, Peppelenlenbosch MP, Tertoolen LGJ, de Laat SW, Kruijer W 1993 Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation. Embo J 12:3789-3798
35. Kozlowski M, Mlinaric-Rascan I, Feng GS, Shen R, Pawson T, Siminovitch KA 1993 Expression and catalytic activity of the tyrosine phosphatase PTP1c is severely impaired in motheaten and viable motheaten mice. J Exp Med 178:2157-2163
36. Riggs BL, Seeman E, Hodgson JF, Taves DR, O'Fallon WM 1982 Effect of fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: comparison with conventional therapy. N Engl J Med 306:446-450
37. Farley JR, Wergedal JE, Baylink DJ 1983 Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science 222:330-332
38. Oreffo ROC, Wells N, Johnstone D 1991 Sodium fluoride does not stimulate mammalian osteoblast-like cells. Calcif Tiss Int 49:150
39. Caverzasio J, Zhen X, Bonjour JP, A G protein-dependent tyrosine phosphorylation process mediates the mitogenic effect of fluoride in osteoblast-like cells. American Society for Bone and Mineral Research 18th Annual Meeting, Seattle, WA, 1996, J Bone Miner Res 11, S1:S385 (Abstract)
40. Burgener D, Bonjour JP, Caverzasio J 1995 Fluoride increases tyrosine kinase activity in osteoblast-like cells: regulatory role for the stimulation of cell proliferation and Pi transport across the plasma membrane. J Bone Miner Res 10:164-171
41. Wu L-W, Yoon HK, Baylink DJ, Graves LM, Lau K-HW 1997 Fluoride at mitogenic doses induces a sustained activation of p44 MAPK, but not p42 MAPK, in human TE85 osteosarcoma cells. J Clin Endocrinol Metab 82:1126-1135
42. Wergedal JE, Lau K-HW 1992 Human bone cells contain a fluoride sensitive acid phosphatase: evidence that this enzyme functions at neutral pH as a phosphotyrosyl protein phosphatase. Clin Biochem 25:47-53
43. Chavassieux P, Chenu C, Valentin-Opran A, Delmas PD, Boivin G, Chapuy MC, Meunier PJ 1993 In vitro exposure to sodium fluoride does not modify proliferation of human osteoblastic cells in primary cultures. J Bone Miner Res 8:37-44
44. Fakkeldij TMV, Rijksen G, Duursma SA, Scheven BAA, Vanadate, but not fluoride, inhibits PTPase activity and MAPK dephosphorylation in human osteoblast-like cells. American Society for Bone and Mineral Research 18th Annual Meeting, Seattle, WA, 1996, J Bone Miner Res 11, S1:S384 (Abstract)
45. Hunter T 1995 Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signalling. Cell 80:225-236
46. MacKintosh C, MacKintosh RW 1994 Inhibitors of protein kinases and phosphatases. Trends Biochem Sci 19:444-448
47. Haystead TAJ, Weiel JE, Litchfield DW, Tsukitani Y, Fischer EH, Krebs EG 1990 Okadaic acid mimics the action of insulin in stimulating protein kinase activity in isolated adipocytes. J Biol Chem 265:16571-16580
48. jnk. Oncogene 11:2553-2563
49. Cowley S, Paterson H, Kemp P, Marshall CJ 1994 Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852
50. Meloche S, Seuwen K, Pages G, Pouyssegur J 1992 Biphasic and synergistic activation of p44(mapK)(ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol 658:845-854
51. Matsumoto J 1994 Vanadate, molybdate and tungstate for orthomolecular medicine. Med Hypotheses 43:177-182
52. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CB 1995 Metabolic effects of sodium metavanadate in humans with insulin-dependent and non-insulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 80:3311-3320